Garnipen-NT Tablet is a combination medication containing Gabapentin 200 mg and Nortriptyline 5 mg, formulated for the management of neuropathic pain and certain types of chronic pain conditions. Gabapentin, an anticonvulsant, modulates calcium channels in the nervous system to reduce nerve excitability, thereby alleviating neuropathic pain symptoms. Nortriptyline, a tricyclic antidepressant, enhances the inhibitory effects of neurotransmitters such as serotonin and norepinephrine, contributing to pain relief and mood stabilization. This synergistic combination targets multiple pain pathways, providing enhanced analgesic efficacy compared to monotherapy. Garnipen-NT is indicated for peripheral neuropathy, postherpetic neuralgia, diabetic neuropathy, and other neuropathic pain syndromes. It may also be beneficial in patients with coexisting depressive symptoms. The medication should be administered as prescribed by a healthcare professional, with dosing individualized based on patient response and tolerability. Common side effects may include dizziness, drowsiness, dry mouth, and gastrointestinal disturbances. Caution is advised in patients with renal impairment, cardiovascular disease, or a history of seizures. Regular monitoring and adherence to prescribed dosage are essential to minimize adverse effects and optimize therapeutic outcomes. Garnipen-NT should not be discontinued abruptly to avoid withdrawal symptoms.